Peter L. Choyke, M.D., F.A.C.R.
- Center for Cancer Research
- National Cancer Institute
- Building 10, Room B3B69F
- Bethesda, MD 20892-1088
Dr. Choyke directs the Molecular Imaging Branch. His research interests include the translation of molecular imaging methods, such as MRI, optical and radionuclide/PET into the clinic. His primary clinical focus is on imaging, diagnosis and therapy of prostate cancer. In the lab, Dr. Choyke focuses on understanding uptake of various PET agents, including PSMA, at the genomic level. In addition, his lab works on the development of new imaging methods for cancer including cell labeling with PET agents, and imaging the tumor microenvironment including immune markers.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
The vision of the Molecular Imaging Branch is to accelerate the development of new treatments for cancer using advanced imaging methods. Dr. Choyke's research interests include the translation of molecular imaging methods, such as MRI, optical and radionuclide/PET into the clinic. His research includes novel methods of detecting ovarian cancer, prostate cancer, angiogenesis, lymphangiogenesis, cancer cell receptor imaging and treatment, cell tracking, and exploration of unique animal models of cancer.
Can Molecular Imaging Measure T-cell Activation?
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Peter L. Choyke, M.D., F.A.C.R.
Dr. Choyke obtained his M.D. from Jefferson Medical College and completed his residency in diagnostic radiology at Yale-New Haven Hospital. Following an imaging fellowship at the University of Pennsylvania, he joined the faculty of Georgetown University and soon thereafter the Diagnostic Radiology Department, Clinical Center, NIH. Since 2004, he has directed the Molecular Imaging Branch within the Center for Cancer Research, NCI
There are no open positions at this time. Check back again later, or take a look at CCR's Careers page.
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
March 4, 2020
NCI Press Release
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. Learn more...
Smarter Prostate Cancer Diagnosis
CCR Milestones 2020
CCR researchers have developed new artificial intelligence tools that will help radiologists improve prostate cancer diagnosis. Learn more...
Seeing Prostate Cancer More Clearly
CCR Milestones 2017
A new imaging method enables sensitive detection and monitoring of high-risk prostate cancers. Learn more...